Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.
Read Full NewsClinical Forum Weighs in: Biologic Selection in Asthma and COPD
Treatable Traits in Asthma and COPD: Clinical Forum Perspectives
Biologic Access in Asthma and COPD: Clinical Forum Perspectives
The designation follows phase 2 ClearMEMory data in which the oral NMDA receptor antagonist improved objective cognitive performance over placebo at 12 weeks.
A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.
The phase 1 ASCEND trial is testing a single intrathecal dose of the investigational AAV9 gene therapy INS1201 in young boys with Duchenne muscular dystrophy.
Findings from the phase 3 METEOROID trial showed that satralizumab reduced the risk of relapse in patients with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.
1.
In schizophrenia, sexual dysfunction is frequent.
2.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
3.
Why breast cancer survivors don't take their medicine, and what can be done about it.
4.
Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.
5.
High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment
1.
Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies
2.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
3.
AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology
4.
Teaching Hematology Through Morphology-Based Learning
5.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
2.
How Iron Deficiency Can Affect Energy and Concentration
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Blood Clotting Disorders Explained
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge